124 related articles for article (PubMed ID: 7655826)
1. Aspects of the design and delivery of microparticles for vaccine applications.
Jenkins PG; Coombes AG; Yeh MK; Thomas NW; Davis SS
J Drug Target; 1995; 3(1):79-81. PubMed ID: 7655826
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
[TBL] [Abstract][Full Text] [Related]
3. Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.
Jones DH; Partidos CD; Steward MW; Farrar GH
Behring Inst Mitt; 1997 Feb; (98):220-8. PubMed ID: 9382743
[TBL] [Abstract][Full Text] [Related]
4. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
Zhao A; Rodgers VG
J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
[TBL] [Abstract][Full Text] [Related]
5. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of micro-encapsulated DNA vaccines.
Jones DH; Clegg JC; Farrar GH
Dev Biol Stand; 1998; 92():149-55. PubMed ID: 9554269
[TBL] [Abstract][Full Text] [Related]
7. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Gupta RK; Chang AC; Siber GR
Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
[TBL] [Abstract][Full Text] [Related]
9. The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.
Jain S; O'Hagan DT; Singh M
Expert Rev Vaccines; 2011 Dec; 10(12):1731-42. PubMed ID: 22085176
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
Kohane DS; Tse JY; Yeo Y; Padera R; Shubina M; Langer R
J Biomed Mater Res A; 2006 May; 77(2):351-61. PubMed ID: 16425240
[TBL] [Abstract][Full Text] [Related]
11. Poly (DL-lactide-co-glycolide) based delivery systems for vaccines and drugs.
Dhiman N; Dutta M; Khuller GK
Indian J Exp Biol; 2000 Aug; 38(8):746-52. PubMed ID: 12557904
[TBL] [Abstract][Full Text] [Related]
12. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
[TBL] [Abstract][Full Text] [Related]
13. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
14. Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines.
Cleland JL
Biotechnol Prog; 1998; 14(1):102-7. PubMed ID: 9496674
[TBL] [Abstract][Full Text] [Related]
15. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology.
Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Mirzadeh H; Fakhari A; Nokhodchi A
J Microencapsul; 2009 Feb; 26(1):1-8. PubMed ID: 18465287
[TBL] [Abstract][Full Text] [Related]
16. New advances in vaccine delivery systems.
Eldridge JH; Staas JK; Chen D; Marx PA; Tice TR; Gilley RM
Semin Hematol; 1993 Oct; 30(4 Suppl 4):16-24; discussion 25. PubMed ID: 8303306
[TBL] [Abstract][Full Text] [Related]
17. Lectins and microparticles for enhanced oral vaccination.
Lavelle EC
Methods; 2006 Feb; 38(2):84-9. PubMed ID: 16406570
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization.
Khang G; Cho JC; Lee JW; Rhee JM; Lee HB
Biomed Mater Eng; 1999; 9(1):49-59. PubMed ID: 10436853
[TBL] [Abstract][Full Text] [Related]
19. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
[TBL] [Abstract][Full Text] [Related]
20. Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid microparticles.
Horie RT; Sakamoto T; Nakagawa T; Tabata Y; Okamura N; Tomiyama N; Tachibana M; Ito J
Laryngoscope; 2010 Feb; 120(2):377-83. PubMed ID: 19950377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
